Hong Kong finds new inflammatory activation pathway in blood vessels after SARS-CoV-2 infection

A study led by The Chinese University of Hong Kong's (CUHK) Faculty of Medicine (CU Medicine) and the LKS Faculty of Med...

February 18, 2022 | Friday | News
Singapore discovers unique lysin capable of killing deadly multi drug-resistant bacteria

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...

February 17, 2022 | Thursday | News
Japan fabricates polymer-DNA gel that could be used in tissue regeneration and robotics

Scientists at Hokkaido University in Japan have made a tuneable, elastic and temperature-sensitive g...

February 17, 2022 | Thursday | News
Singapore finds why Alzheimer’s disease females face faster memory decline

A joint study by Nanyang Technological University, Singapore (NTU Singapore) and National University of Singapore (NUS) ...

February 16, 2022 | Wednesday | News
Japan discovers host immune-dependent novel anti-coronavirus antibody

The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), in partnership with Shionogi & Co....

February 16, 2022 | Wednesday | News
Genetic research in NZ offers hope for preventing Parkinson’s disease

There’s new hope for treating Parkinson’s disease with the publication of groundbreaking genetic research fr...

February 15, 2022 | Tuesday | News
Singapore develops method for creating promising new sulphur-based medicines

A key technical challenge in creating new sulphur-based medicines has been overcome by scientists at Nanyang Techno...

February 15, 2022 | Tuesday | News
Indian startup Bugworks Research secures $18M to advance work in AMR

Indian startup Bugworks Research, with operations in US and Australia, has announced the financing of $18M Ser...

February 9, 2022 | Wednesday | News
Korea's Bridge Biotherapeutics to uncover new druggable sites in oncology, immunology

Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for inflam...

February 8, 2022 | Tuesday | News
US-India collaborate for development, commercialisation of first-in-class bone health drugs

CSIR-Central Drug Research Institute (CDRI), Lucknow, one of the premier drug research institutions in India and Aveta B...

February 3, 2022 | Thursday | News
NZ discovers link between high blood pressure and diabetes

Scientists at the universities of Auckland and Bristol are preparing to test a novel medication on patients with a poten...

February 2, 2022 | Wednesday | News
Hong Kong identifies potential biomarker for early diagnosis of liver cancer

A research team at the Department of Pathology, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) in collabo...

February 2, 2022 | Wednesday | News
Australia seeks partners to upscale biotech facility in NSW

New South Wales (NSW) will leverage its world-class cell and gene therapy expertise to establish Australia’s first...

February 2, 2022 | Wednesday | News
Hong Kong examines eye health in school children, finds myopia deepening faster

Two research teams from The Hong Kong Polytechnic University (PolyU) found that not only did the rate of myopia progress...

January 31, 2022 | Monday | News
Australia targets bacteria behind respiratory infections

Researchers in Australia have discovered a way to kill a type of bacteria that causes millions of respiratory infections...

January 31, 2022 | Monday | News
Australia accelerates 'Microbiome Medicine' with new partnership between BiomeBank & Hudson Institute

The translation of research into the development of innovative and life-saving microbial therapies is set to transform i...

January 27, 2022 | Thursday | News
ENDRA Life Sciences expands into China with Shanghai General Hospital partnership

US-based ENDRA Life Sciences Inc. has received Institutional Review Board approval from China’s Shanghai...

January 25, 2022 | Tuesday | News
Singapore develops new therapeutic approach to treat metabolic disorders

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a new therapeutic approach to o...

January 25, 2022 | Tuesday | News